Evaluation of serum soluble HLA-G levels post-recovery from COVID-19 and post-vaccination (Sinopharm and Pfizer-BioNTech)

Serum soluble HLA-G (sHLA-G) levels have been shown to be upregulated in COVID-19 patients. In this study, sHLA-G levels were examined in COVID-19 patients 14–21 days post-recovery (100 patients) and 80 uninfected controls. In addition, individuals vaccinated with Sinopharm or Pfizer-BioNTech (50 in...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamed, Roaa M., Mahmood, Majid M., Ad'hiah, Ali H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. 2023
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637515/
https://www.ncbi.nlm.nih.gov/pubmed/36369216
http://dx.doi.org/10.1016/j.humimm.2022.11.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637515/
https://www.ncbi.nlm.nih.gov/pubmed/36369216
http://dx.doi.org/10.1016/j.humimm.2022.11.002

Ejemplares similares